Andrew Garfinkle, MD, PHD
Ophthalmology Physician in Gilford, New Hampshire.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Andrew Garfinkle, MD, PHD reported a CMS MIPS final score of 91.2/100 - above the 83.1 national average - and filed 690 Medicare Part D claims in 2023.
- 91.2/100
- MIPS score · +8 vs avg
- 690
- Part D claims, 2023
- 54%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Andrew Garfinkle, MD, PHD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Andrew Garfinkle, MD, PHD sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Andrew Garfinkle, MD, PHD writes more Part D claims than 34% of them and scores higher on MIPS quality than 60% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Andrew Garfinkle, MD, PHD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Andrew Garfinkle, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Andrew Garfinkle, MD, PHD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Hampshire
How Ophthalmology Physician compares to other specialties among New Hampshire providers
Ophthalmology Physician ranks #60 among New Hampshire's specialties (0.3% of in-state providers)
Each bar is a specialty's share of the New Hampshire provider total, by primary NUCC taxonomy. The highlighted bar is Ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Andrew Garfinkle, MD, PHD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 91.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 91.2/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Ophthalmology Physician US NPIs
91.2/100 MIPS final score - 8.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 82.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Andrew Garfinkle, MD, PHD appears in the CMS NPPES registry as an Ophthalmology Physician provider holding MD, PHD credentials at 368 HOUNSELL AVE, Gilford, NH, 03249, with a listed phone of (603) 524-2020. NPI 1720074982 was issued on 09/23/2005.
Medicare Part D records for calendar year 2023 show 690 prescription claims written by this provider, covering 243 Medicare beneficiaries and totaling roughly $167K in drug spend, split 46% brand-name and 54% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.2/100 for the 2023 performance year (Quality 82.3), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1720074982 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD, PHD |
| Gender | Male |
| NPI Issued | 09/23/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Andrew Garfinkle, MD, PHD's current license status, disciplinary history, and board certifications with the New Hampshire Board of Medicine in New Hampshire before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1720074982 is the unique 10-digit identifier CMS uses to link Garfinkle across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Brand vs generic prescribing mix · Above average
46% brand-name claims vs 54% generic, on 690 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,319
- Total Day Supply
- 37,115
- Brand vs Generic
- 46% brand / 54% generic
- Brand Drug Cost
- $141K
- Generic Drug Cost
- $26K
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 76.9 years
- Avg HCC Risk Score
- 0.93
- Gender Split
- 60% female / 40% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Andrew Garfinkle, MD, PHD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Tobramycin-Dexamet…
Tobramycin-Dexamethasone
178 claims
- Latanoprost
Latanoprost
129 claims
- Lumigan
Lumigan
115 claims
- Brimonidine Tartra… 35
Brimonidine Tartrate-Timolol
35 claims
- Dorzolamide-Timolol 34
Dorzolamide-Timolol
34 claims
- Combigan 26
Combigan
26 claims
- Timolol Maleate 24
Timolol Maleate
24 claims
- Travoprost 18
Travoprost
18 claims
| Drug | Claims |
|---|---|
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 178 |
| Latanoprost | 129 |
| Lumigan Bimatoprost | 115 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 35 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 34 |
| Combigan Brimonidine Tartrate/Timolol | 26 |
| Timolol Maleate | 24 |
| Travoprost | 18 |
| Brimonidine Tartrate | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Andrew Garfinkle, MD, PHD fits within the Ophthalmology Physician landscape nationally.
Andrew Garfinkle, MD, PHD's 690 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in New Hampshire
Other clinicians with the same primary specialty enrolled in New Hampshire, drawn from the same CMS NPPES roster as Garfinkle.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Hampshire medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Hampshire
Frequently Asked Questions
What is Andrew Garfinkle, MD, PHD's specialty? ▼
How much does Andrew Garfinkle, MD, PHD prescribe under Medicare Part D? ▼
What is Andrew Garfinkle, MD, PHD's Medicare quality score? ▼
Where is Andrew Garfinkle, MD, PHD located? ▼
What is Andrew Garfinkle, MD, PHD's NPI number? ▼
Does Andrew Garfinkle, MD, PHD prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does Andrew Garfinkle, MD, PHD prescribe most often? ▼
Does Andrew Garfinkle, MD, PHD accept Medicare? ▼
How can I verify Andrew Garfinkle, MD, PHD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.